# Study of the EpiVacCorona Vaccine With the Involvement of Volunteers Aged 60 Years and Above

> **NCT05021016** · PHASE3 · COMPLETED · sponsor: **Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector"** · enrollment: 150 (actual)

## Conditions studied

- Covid19

## Interventions

- **BIOLOGICAL:** EpiVacCorona (EpiVacCorona vaccine based on peptide antigens for the prevention of COVID-19)

## Key facts

- **NCT ID:** NCT05021016
- **Lead sponsor:** Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector"
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-19
- **Primary completion:** 2021-01-30
- **Final completion:** 2021-01-30
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2021-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05021016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05021016, "Study of the EpiVacCorona Vaccine With the Involvement of Volunteers Aged 60 Years and Above". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05021016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*